Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by mitch0frenchon Feb 24, 2017 10:44am
343 Views
Post# 25888814

RE:RE:RE:Feb 24, 2017 Pulmonary Fibrosis News IPF - ProMetic

RE:RE:RE:Feb 24, 2017 Pulmonary Fibrosis News IPF - ProMetic Yes more patients will have been better , but the results are very good and the weeks passing ,are in favor of PBI .
Time (delay) is making the proof of superiority of PBI , but time(delay) is in favor of the manipulator as we see this morning.Thath's bothering me!
Maybe 9 patients is not enough but 9 manipulators with cash is more than enough to do wat they want with the price of the shares , that's the reality in this world  and it is not to change!!!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities